COVID-19 vaccination acceptance and its associated factors among the Iraqi population: a cross sectional study
Purpose The Coronavirus Disease 2019 (COVID-19) pandemic poses a serious threat to
countless lives. Development of an efficient vaccination can help end the pandemic. Vaccine …
countless lives. Development of an efficient vaccination can help end the pandemic. Vaccine …
[图书][B] The Islamic Republic of Iran: a primary health care case study in the context of the COVID-19 pandemic
Page 1 The Islamic Republic of Iran: a primary health care case study in the context of the
COVID-19 pandemic Amirhossein Takian Ahad Bakhtiari Jafar Sadegh Tabrizi Azam Raoofi …
COVID-19 pandemic Amirhossein Takian Ahad Bakhtiari Jafar Sadegh Tabrizi Azam Raoofi …
[PDF][PDF] Deep Learning-based CAD System for Predicting the COVID-19 X-ray Images
AR Talib, A Hana'M - Karbala International Journal of Modern Science, 2023 - iasj.net
Abstract According to World Health Organization data, Coronavirus (COVID-19) has infected
about 660, 378, 145 patients around the world. It is nonetheless difficult for physicians to …
about 660, 378, 145 patients around the world. It is nonetheless difficult for physicians to …
[PDF][PDF] Assessment of the Iraqi Health Staff Response to COVID-19 Outbreak: Basra an Example
AH Abed, DA Abdulwahid, HA Jassim… - University of Thi-Qar …, 2024 - jmed.utq.edu.iq
Assessment of the Iraqi Health Staff Response to COVID-19 Outbreak: Basra an Example
Page 1 Thi-Qar Medical Journal (TQMJ):Vol.( 27),No.(1),2024 Web Site: https://jmed.utq.edu …
Page 1 Thi-Qar Medical Journal (TQMJ):Vol.( 27),No.(1),2024 Web Site: https://jmed.utq.edu …
[PDF][PDF] Coronavirus Vaccine and Pregnancy: An Overview of Potential Influences and Implications for Vaccinated Women
WA Ameen, WM Hadi, M Abd Al-Kareem, AS Alzuheri… - researchgate.net
Coronavirus disease (COVID-19) is a developing coronavirus infection (SARS-CoV-2). The
majority of patients who contract COVID-19 experience mild to moderate symptoms and …
majority of patients who contract COVID-19 experience mild to moderate symptoms and …